138
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Psoriatic Dermal-Derived Mesenchymal Stem Cells Induced C3 Expression in Keratinocytes

, , , , , , , , ORCID Icon & show all
Pages 1489-1497 | Received 23 Feb 2022, Accepted 22 Jul 2022, Published online: 02 Aug 2022

References

  • Griffiths CEM, van der Walt JM, Ashcroft DM, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017;177(1):e4–e7. doi:10.1111/bjd.15610
  • Mahler R, Jackson C, Ijacu H. The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey. J Cutan Med Surg. 2009;13(6):283–293. doi:10.2310/7750.2009.08083
  • Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. 2012;22(5):663–667. doi:10.1684/ejd.2012.1802
  • Gamret AC, Alexandra P, Raymond MF, et al. Complementary and alternative medicine therapies for psoriasis. JAMA Dermatol. 2018;154:1330–1337. doi:10.1001/jamadermatol.2018.2972
  • Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32(1):227–255. doi:10.1146/annurev-immunol-032713-120225
  • Li JQ, Lin HX, Hou RX, et al. Multi-omics study in monozygotic twins confirm the contribution of de novo mutation to psoriasis. J Autoimmun. 2020;106:102349. doi:10.1016/j.jaut.2019.102349
  • Schonthaler HB, Guinea-Viniegra J, Stefanie KW, et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 2013;39(6):1171–1181. doi:10.1016/j.immuni.2013.11.011
  • Bussche L, Gerlinde R. Peripheral blood-derived mesenchymal stromal cells promote angiogenesis via paracrine stimulation of vascular endothelial growth factor secretion in the equine model. Stem Cells Transl Med. 2014;3(12):1514–1525. doi:10.5966/sctm.2014-0138
  • Hou RX, Yan H, Niu XP, et al. Gene expression profile of dermal mesenchymal stem cells from patients with psoriasis. J Eur Acad Dermatol. 2014;28(12):1782–1791. doi:10.1111/jdv.12420
  • Hou RX, Yin GH, An P, et al. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes. J Dermatol Sci. 2013;72(2):103–109. doi:10.1016/j.jdermsci.2013.07.002
  • Li J, Wang HL, Du CB, et al. hUC-MSCs ameliorated CUMS-induced depression by modulating complement C3 signaling-mediated microglial polarization during astrocyte-microglia crosstalk. Brain Res Bull. 2020;163:109–119. doi:10.1016/j.brainresbull.2020.07.004
  • Tu ZD, Li Q, Bu H, et al. Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev. 2010;19(11):1803–1809. doi:10.1089/scd.2009.0418
  • Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105(7):2821–2827. doi:10.1182/blood-2004-09-3696
  • Chang WJ, Niu XP, Hou RX, et al. LITAF, HHEX, and DUSP1 expression in mesenchymal stem cells from patients with psoriasis. Genet Mol Res. 2015;14(4):15793–15801. doi:10.4238/2015.December.1.31
  • Liu RF, Wang F, Wang Q, et al. Research note mesenchymal stem cells from skin lesions of psoriasis patients promote proliferation and inhibit apoptosis of HaCaT cells. Genet Mol Res. 2015;14(4):17758–17767. doi:10.4238/2015.December.21.49
  • Santos JM, Camões SP, Filipe E, et al. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing. Stem Cell Res Ther. 2015;6(1). doi:10.1186/s13287-015-0082-5
  • Liu RF, Wang Y, Zhao XC, et al. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin. Eur J Dermatol. 2014;24(5):560–567. doi:10.1684/ejd.2014.2394
  • Li XH, Li JQ, Lu FN, et al. Role of SPRED1 in keratinocyte proliferation in psoriasis. J Dermatol. 2020;47(7):735–742. doi:10.1111/1346-8138.15369
  • Li JQ, Xing JX, Lu FN, et al. Psoriatic dermal-derived mesenchymal stem cells reduce keratinocyte junctions, and increase glycolysis. Acta DV. 2020;100(8):adv00122–7.
  • Wang Y, Liang YY, Li J, et al. Expression and functional regulation of gap junction protein Connexin 43 in dermal mesenchymal stem cells from psoriasis patients. Acta Histochem. 2020;122(4):151550. doi:10.1016/j.acthis.2020.151550
  • Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. doi:10.1056/NEJMra0804595
  • Ekman AK, Vegfors J, Bivik EC, et al. Overexpression of psoriasin (S100A7) contributes to dysregulated differentiation in psoriasis. Acta DV. 2017;97:441–448.
  • Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol. 2007;171(3):715–727. doi:10.2353/ajpath.2007.070166
  • Basset-Séguin PM, Dereure O, Mils V, et al. C3d, g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation. J Invest Dermatol. 1993;101(6):827–831. doi:10.1111/1523-1747.ep12371702
  • Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol. 2008;181(10):7420–7427. doi:10.4049/jimmunol.181.10.7420
  • Nacken W, Roth J, Sorg C, et al. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech. 2003;60(6):569–580. doi:10.1002/jemt.10299
  • Volanakis JE. Transcriptional regulation of complement genes. Annu Rev Immunol. 1995;13:277–305. doi:10.1146/annurev.iy.13.040195.001425
  • Terui T, Funayama M, Terunuma A, et al. Ultraviolet B radiation exerts enhancing effects on the production of a complement component, C3, by interferon-gamma-stimulated cultured human epidermal keratinocytes, in contrast to photochemotherapy and ultraviolet A radiation that show suppressive effects. Br J Dermatol. 2000;142:660–668. doi:10.1046/j.1365-2133.2000.03410.x
  • Chimenti MS, Perricone C, Graceffa D, et al. Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. Clin Exp Rheumatol. 2012;30:23–30.
  • Markowitz J, Carson WE. Review of S100A9 biology and its role in cancer. Biochim Biophys Acta. 2013;1835(1):100–109. doi:10.1016/j.bbcan.2012.10.003
  • Lim SY, Raftery MJ, Goyette J, et al. S-Glutathionylation regulates inflammatory activities of S100A9. J Biol Chem. 2010;285(19):14377–14388. doi:10.1074/jbc.M109.075242
  • Vincent F. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366:1736–1743. doi:10.1016/S0140-6736(05)67700-8